Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Income from Non-Controlling Interests came in at -$2341.5 in Q1 2026, up 25.8% year-on-year from -$1861.3 in Q1 2025, and up 32.95% on a QoQ basis from -$3492.1 in Q4 2025.
Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Income from Non-Controlling Interests data on file, last reported at -$2341.5 in Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests rose 25.8% year-over-year to -$2341.5 in Q1 2026; TTM through Mar 2026 was -$8171.7, a 41.66% increase from a year earlier, with the FY2025 full-year figure at -$9312.3, up 27.38% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$2341.5, up from -$3492.1 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for STVN reached as high as $99236.3 in Q2 2022 and fell as low as -$39789.6 in Q4 2022.
- Historically, Income from Non-Controlling Interests has averaged $13603.0 across 5 years, with a median of -$2163.2 in 2024.
- Across the five-year window, Income from Non-Controlling Interests surged 423.99% in 2022 and slumped 404.42% in 2024, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at -$39789.6 in 2022, then surged by 105.41% to $2151.9 in 2023, then plunged by 248.98% to -$3205.8 in 2024, then slipped by 8.93% to -$3492.1 in 2025, then soared by 32.95% to -$2341.5 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$2341.5 in Q1 2026, -$3492.1 in Q4 2025, and -$2338.1 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.12 Bn | 120.90 Bn | 1.96 Bn | -18.70 Mn |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | - |
| 4 | Medline | 32.81 Bn | 30.58 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 29.44 Bn | 27.78 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.12 Bn | 22.68 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | - |
| 10 | Stevanato Group S.p.A | 5.42 Bn | 5.28 Bn | 88.01 Mn | -2,341.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,341.49 |
| Dec 31, 2025 | -3,492.13 |
| Sep 30, 2025 | -2,338.11 |
| Mar 31, 2025 | -3,155.65 |
| Dec 31, 2024 | -3,205.79 |
| Sep 30, 2024 | -5,491.10 |
| Jun 30, 2024 | -2,153.78 |
| Mar 31, 2024 | -2,172.72 |
| Dec 31, 2023 | 2,151.88 |
| Sep 30, 2023 | -1,088.59 |
| Jun 30, 2023 | 43,556.98 |
| Mar 31, 2023 | 19,320.15 |
| Dec 31, 2022 | -39,789.65 |
| Sep 30, 2022 | 72,595.75 |
| Jun 30, 2022 | 99,236.27 |
| Mar 31, 2022 | 46,015.85 |
| Dec 31, 2021 | -82,365.91 |
| Sep 30, 2021 | -22,406.46 |
| Jun 30, 2021 | 30,106.79 |
| Mar 31, 2021 | 16,887.31 |